Remote Follow-up of Patients Receiving Implantable Cardioverter Defibrillator for Prophylactic Therapy
REFORM
Remote Follow-up for ICD-Therapy in Patients Meeting MADIT II Criteria (REFORM)
1 other identifier
interventional
155
2 countries
5
Brief Summary
The completed MADIT II study has shown that implantation of a cardioverter-defibrillator (ICD) in patients with a reduced left ventricular ejection fraction and a prior myocardial infarction reduces death from any cause. The probability of the first therapy due to ventricular tachyarrhythmia was about 34% within 3 years. With a 3-month ICD-follow-up scheme, as it is in the standard ICD therapy, the majority of patients is followed more closely than necessary with respect to anti-tachyarrhythmia ICD therapy. A Home Monitoring (HM) function has been integrated into several ICD models from Biotronik (Berlin , Germany), for close remote monitoring of ICD patients. The HM function may substitute in-clinic follow-up controls. The objective of our study is to compare a standard 3-month follow-up scheme and a 12-month follow-up scheme using HM in ICD recipients with the "MADIT II indications". The comparison should be made with respect to the difference in follow-up burden and the associated costs, and regarding possible impact of the remote follow-up via HM on all cause mortality, hospitalization, and patients' quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jan 2004
Longer than P75 for phase_4
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
November 17, 2006
CompletedFirst Posted
Study publicly available on registry
November 20, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedJanuary 17, 2011
July 1, 2008
4.5 years
November 17, 2006
January 14, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of follow-up visits
27 months
Secondary Outcomes (4)
Total costs
27 months
Mortality from any cause
27 months
Quality of life (SF-36)
27 months
Hospitalization
27 months
Study Arms (2)
1
EXPERIMENTALProlonged follow-up intervals every 12 months
2
ACTIVE COMPARATORStandard follow-up intervals of 3 months
Interventions
ICD with Biotronik Home Monitoring capability
Eligibility Criteria
You may qualify if:
- Indication for implantation of an implantable cardioverter-defibrillator (ICD) according to the patient selection criteria used in the MADIT-II trial:
- Myocardial infarction 1 month or more prior to entry
- Ejection fraction of 30% or less within 3 months before entry
You may not qualify if:
- NYHA functional class IV
- Coronary revascularization later than 5 days after ICD implantation
- First myocardial infarction within the past month
- Advanced cerebrovascular disease
- Any condition with a likelihood of death within the next 12 months
- Pacing indication
- Conventional ICD indication (i.e., criteria other than MADIT II)
- Living in an area with insufficient GSM coverage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Institute of clinical and experimental medicine
Prague, 14021, Czechia
Hospital Na Homolce
Prague, 15030, Czechia
Zentralklinik Bad Berka
Bad Berka, 99437, Germany
Herz- und Gefäßklinikum Bad Neustadt GmbH
Bad Neustadt an der Saale, 97616, Germany
Herzzentrum der Universität Leipzig
Leipzig, 04289, Germany
Related Publications (2)
Elsner C, Sommer P, Piorkowski C, Taborsky M, Neuser H, Bytesnik J, Geller J, Kottkamp H, Wiesmeth H, Hindricks G. A prospective multicenter comparison trial of Home Monitoring against regular follow-up in MADIT II patients: additional visits and cost impact. Comput Cardiol 33: 241-244, 2006.
RESULTHindricks G, Elsner C, Piorkowski C, Taborsky M, Geller JC, Schumacher B, Bytesnik J, Kottkamp H. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial. Eur Heart J. 2014 Jan;35(2):98-105. doi: 10.1093/eurheartj/eht207. Epub 2013 Jul 18.
PMID: 23868932DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gerhard Hindricks, Prof. Dr.
Herzzentrum Leipzig, Germany
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 17, 2006
First Posted
November 20, 2006
Study Start
January 1, 2004
Primary Completion
July 1, 2008
Study Completion
July 1, 2008
Last Updated
January 17, 2011
Record last verified: 2008-07